News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
93,846 Results
Type
Article (6806)
Company Profile (39)
Press Release (87001)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (27899)
Career Advice (134)
Deals (4018)
Drug Delivery (32)
Drug Development (14148)
Employer Resources (12)
FDA (2891)
Job Trends (2132)
News (49494)
Policy (6039)
Tag
Academia (431)
Accelerated approval (3)
Adcomms (7)
Allergies (33)
Alliances (9103)
ALS (13)
Alzheimer's disease (266)
Antibody-drug conjugate (ADC) (49)
Approvals (2881)
Artificial intelligence (49)
Autoimmune disease (9)
Automation (3)
Bankruptcy (20)
Best Places to Work (1811)
BIOSECURE Act (16)
Biosimilars (78)
Biotechnology (26)
Bladder cancer (25)
Brain cancer (6)
Breast cancer (55)
Cancer (501)
Cardiovascular disease (24)
Career advice (116)
Career pathing (3)
CAR-T (21)
Cell therapy (88)
Cervical cancer (4)
Clinical research (11577)
Collaboration (200)
Compensation (47)
Complete response letters (9)
COVID-19 (549)
CRISPR (6)
C-suite (55)
Cystic fibrosis (13)
Data (482)
Denatured (2)
Depression (7)
Diabetes (39)
Diagnostics (568)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (26)
Drug pricing (26)
Drug shortages (1)
Duchenne muscular dystrophy (29)
Earnings (9673)
Editorial (8)
Employer branding (3)
Employer resources (10)
Events (12017)
Executive appointments (128)
FDA (3275)
Frontotemporal dementia (2)
Funding (152)
Gene editing (26)
Generative AI (6)
Gene therapy (88)
GLP-1 (109)
Government (1331)
Grass and pollen (1)
Guidances (36)
Healthcare (1964)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (47)
Indications (10)
Infectious disease (587)
Inflammatory bowel disease (52)
Inflation Reduction Act (4)
Influenza (17)
Intellectual property (12)
Interviews (11)
IPO (1838)
IRA (13)
Job creations (389)
Job search strategy (112)
Kidney cancer (2)
Labor market (2)
Layoffs (59)
Leadership (1)
Legal (560)
Liver cancer (13)
Lung cancer (80)
Lymphoma (32)
Machine learning (2)
Management (2)
Manufacturing (123)
MASH (14)
Medical device (1182)
Medtech (1183)
Mergers & acquisitions (2281)
Metabolic disorders (92)
Multiple sclerosis (19)
NASH (2)
Neurodegenerative disease (18)
Neuropsychiatric disorders (1)
Neuroscience (346)
NextGen: Class of 2025 (714)
Non-profit (358)
Now hiring (11)
Obesity (33)
Opinion (48)
Ovarian cancer (22)
Pain (9)
Pancreatic cancer (14)
Parkinson's disease (9)
Partnered (3)
Patents (32)
Patient recruitment (20)
Peanut (21)
People (8038)
Pharmaceutical (11)
Pharmacy benefit managers (3)
Phase I (3811)
Phase II (4821)
Phase III (4244)
Pipeline (366)
Policy (58)
Postmarket research (298)
Preclinical (1501)
Press Release (66)
Prostate cancer (19)
Psychedelics (5)
Radiopharmaceuticals (38)
Rare diseases (73)
Real estate (922)
Recruiting (4)
Regulatory (4827)
Reports (11)
Research institute (390)
Resumes & cover letters (12)
RNA editing (1)
RSV (11)
Schizophrenia (12)
Series A (35)
Series B (13)
Service/supplier (3)
Sickle cell disease (7)
Special edition (4)
Spinal muscular atrophy (21)
Sponsored (9)
Startups (575)
State (1)
Stomach cancer (3)
Supply chain (11)
Tariffs (13)
The Weekly (4)
Vaccines (196)
Venture capitalists (6)
Weight loss (16)
Women's health (3)
Date
Last 7 days (190)
Last 30 days (557)
Last 365 days (6162)
2025 (2323)
2024 (6514)
2023 (6984)
2022 (9084)
2021 (9507)
2020 (8215)
2019 (5873)
2018 (4545)
2017 (5079)
2016 (4624)
2015 (5279)
2014 (3730)
2013 (2904)
2012 (2994)
2011 (3168)
2010 (2589)
Location
Africa (93)
Alabama (12)
Alaska (1)
Arizona (12)
Arkansas (2)
Asia (7557)
Australia (891)
California (1236)
Canada (253)
China (183)
Colorado (34)
Connecticut (29)
Delaware (48)
Europe (13990)
Florida (155)
Georgia (19)
Idaho (13)
Illinois (54)
India (12)
Indiana (41)
Iowa (2)
Japan (31)
Kansas (4)
Kentucky (9)
Louisiana (2)
Maine (6)
Maryland (329)
Massachusetts (865)
Michigan (26)
Minnesota (50)
Mississippi (1)
Missouri (15)
Montana (5)
Nebraska (1)
Nevada (4)
New Hampshire (3)
New Jersey (481)
New Mexico (4)
New York (354)
North Carolina (206)
North Dakota (8)
Northern California (523)
Ohio (42)
Oklahoma (7)
Oregon (3)
Pennsylvania (202)
Puerto Rico (1)
Rhode Island (5)
South America (137)
South Carolina (2)
Southern California (526)
Tennessee (3)
Texas (166)
United States (4466)
Utah (26)
Virginia (19)
Washington D.C. (6)
Washington State (99)
Wisconsin (9)
93,846 Results for "cobra biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to share additional data from its diagnostic 64Cu-SAR-bisPSMA trial, COBRA.
March 8, 2024
·
11 min read
Biotech Bay
Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today issued the following statement about the closure of COBRA, a minimum residual disease (MRD) study.
September 1, 2023
·
3 min read
Press Releases
Bora Biologics Unveils Cutting-Edge Innovations at Festival of Biologics 2025
April 17, 2025
·
2 min read
Press Releases
Solvias to Speak at Festival of Biologics 2025 on Building Robust CMC Assays for Biologic Therapies
April 23, 2025
·
2 min read
Press Releases
ADMA Biologics Statement on Tariffs
April 8, 2025
·
4 min read
Manufacturing
Merck Snaps Up WuXi Biologics Facility in Ireland for $500M
The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s manufacturing operations in Ireland.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Theriva™ Biologics to Present at the 2025 NeauxCancer Conference
March 20, 2025
·
2 min read
Press Releases
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
April 24, 2025
·
3 min read
Press Releases
FairJourney Biologics Establishes Supervisory Board
March 25, 2025
·
4 min read
Press Releases
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
May 7, 2025
·
5 min read
1 of 9,385
Next
